Differential roles for the coactivators CBP and p300 on TCF/β-catenin-mediated survivin gene expression

Oncogene

Volumn 24, Issue 22, 2005, Pages 3619-3631

  Ma, Hong ^a   Nguyen, Cu ^a   Lee, Kyung Soon ^a   Kahn, Michael ^a,b  

^a Institute for Chemical Genomics   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

CBP; p300; Survivin; TCF catenin

Indexed keywords

BETA CATENIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; HISTONE DEACETYLASE 1; ICG 001; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN INHIBITOR; PROTEIN P300; SMALL INTERFERING RNA; SUMO 1 PROTEIN; SURVIVIN; UNCLASSIFIED DRUG;

ARTICLE; CHROMATIN; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION; WILD TYPE;

ANIMALS; APOPTOSIS; BETA CATENIN; BICYCLO COMPOUNDS, HETEROCYCLIC; CASPASE 3; CASPASES; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; E1A-ASSOCIATED P300 PROTEIN; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NEOPLASMS; NUCLEAR PROTEINS; PYRIMIDINONES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 19944422429     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208433     Document Type: Article

References (52)

1. Abarzua P, LoSardo JE, Gubler ML and Neri A. (1995). Cancer Res., 55, 3490-3494.
2. Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, Dombret H, Reyes F, Diebold J, Gisselbrecht C, Salles G, Altieri DC and Molina TJ. (2000). Blood, 96, 1921-1925.
3. Altieri DC. (2003a). Nat Rev Cancer, 3, 46-54.
4. Altieri DC. (2003b). Methods Mot Biol., 223, 533-542.
5. Ambrosini G, Adida C and Altieri DC. (1997). Nat Med., 8, 917-921.
6. Bafico A, Liu G, Goldin L, Harris V and Aaronson SA. (2004). Cancer Cell, 6, 497-506.
7. Baluchamy S, Rajabi HN, Thimmapapy R, Navaraj A and Thimmapaya B. (2003). Proc. Natl. Acad. Sci. USA, 100, 9524-9529.
8. Chesire DR and Isaacs WB. (2003). Endocr. Relat. Cancer, 10, 537-560.
9. Deveraux QL and Reed JC. (1999). Genes Dev., 13, 239-252.
10. Emami KH, Nguyen C, Ma H, Kim DH, Jeong KW, Eguchi M, Moon RT, Teo JL, Oh SW, Lee SC, Kim HY, Moon SH, Ha J and Kahn M. (2004). Proc. Natl. Acad. Sci. USA, 101, 12682-12687.
11. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC. (1992). Cell, 69, 119-128.
12. Giles RH, Peters DJ and Bruening MH. (1998). Trends Genet., 14, 178-183.
13. Girdwood D, Bumpass D, Vaughan OA, Thain A, Anderson LA, Snowden AW, Garcia-Wilson E, Perkins ND and Hay RT. (2003). Mol. Cell, 11, 1043-1054.
14. Goodman RH and Smolik S. (2000). Genes Dev, 14, 1553-1577.
15. Goyette MC, Cho K, Fasching CL, Levy DB, Kinzler KW, Paraskeva C, Vogelstein B and Stanbridge EJ, (1992). Mol. Cell. Biol., 12, 1387-1395.
16. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW. (1998). Science, 281, 1438-1441.
17. Ilyas M, Tomlinson IP, Rowan A, Pignatelli M and Bodmer WF. (1997). Proc. Natl. Acad. Sci. USA, 94, 10330-10334.
18. Jiang MC, Yang-Yen HF, Lin JK and Yen JJ. (1996). Oncogene, 13, 609-616.
19. Kawasaki H, Eckner R, Yao TP, Taira K, Chiu R, Livingston DM and Yokoyama KK. (1998). Nature, 393, 284-289.
20. Kim JS, Crooks H, Dracheva T, Nishanian TG, Singh B, Jen J and Waldman T. (2002). Cancer Res., 62, 2744-2748.
21. Kim PJ, Plescia J, Clevers H, Fearon ER and Altieri DC. (2003). Lancet, 362, 205-209.
22. Kumar K and Vaux DL. (2002). Science, 297, 1291.
23. Kung AL, Rebel VI, Bronson RT, Ch'ng LE, Sieff CA, Livingston DM and Yao TP. (2000). Genes Dev., 14, 272-277.
24. LaCasse EC, Baird S, Korneluk RG and MacKenzie AE. (1998). Oncogene, 17, 3247-3259.
25. Lee YJ, Kim JH, Bae S, Rho SK and Choe SY. (2004). Mol. Cell, 17, 217-222.
26. Li F. (2003). J. Cell Physiol., 197, 8-29.
27. Li F, Ackermann EJ, Bennett CF, Rothermel AL, Plescia J, Tognin S, Villa A, Marchisio PC and Altieri DC. (1999). Nat. Cell. Biol., 1, 461-466.
28. Li F and Altieri DC. (1999). Biochem. J., 344, 305-311.
29. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC and Altieri DC. (1998). Nature, 396, 580-584.
30. Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG and Hung MC. (2000). Proc. Natl. Acad. Sci. USA, 97, 4262-4266.
31. Maeda O, Usami N, Kondo M, Takahashi M, Goto H, Shimokata K, Kusugami K and Sekido Y. (2004). Oncogene, 29, 964-972.
32. Miyagishi M, Fujii R, Hatta M, Yoshida E, Araya N, Nagafuchi A, Ishihara S, Nakajima T and Fukamizu A. (2000). J. Biol. Chem., 1275, 35170-35175.
33. O'Connor DS, Grossman D, Plescia J, Li F, Zhang H, Villa A, Tognin S, Marchisio PC and Altieri DC. (2000). Proc. Natl. Acad. Sci. USA, 97, 13103-13107.
34. O'Connor DS, Wall NR, Porter AC and Altieri DC. (2002). Cancer Cell, 2, 43-15.
35. Omura S, Iwai Y, Hirano A, Nakagawa A, Awaya J, Tsuchiya H, Takahashi Y and Masuma R. (1977). J. Antibiotics, 30, 275.
36. Owens DM and Watt FM. (2003). Nat. Rev. Cancer, 3, 444-451.
37. Pelengaris S, Khan M and Evan G. (2002). Nat. Rev. Cancer, 2, 764-776.
38. Rebel VI, Kung AL, Tanner EA, Yang H, Bronson RT and Livingston DM. (2002). Proc. Natl. Acad. Sci. USA, 99, 14789-14794.
39. Roth JF, Shikama N, Henzen C, Desbaillets I, Lutz W, Marino S, Wittwer J, Schorle H, Gassmann M and Eckner R. (2003). EMBO J., 22, 5186-5196.
40. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R and Ben-Ze'ev A. (1999). Proc. Natl. Acad. Sci. USA, 96, 5522-5527.
41. Speliotes EK, Uren A, Vaux D and Horvitz HR. (2000). Mol. Cell, 6, 211-223.
42. Spencer VA, Sun JM, Li L and Davie LR. (2003). Methods, 31, 67-75.
43. Suganuma T, Kawabata M, Ohshima T and Ikeda MA. (2002). Proc. Natl. Acad. Sci. USA, 99, 13073-13078.
44. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T and Reed JC. (1998). Cancer Res., 58, 5315-5320.
45. Tetsu O and McCormick F. (1999). Nature, 398, 422-426.
46. Tu SP, Jiang XH, Lin MC, Cui JT, Yang Y, Lum CT, Zou B, Zhu YB, Jiang SH, Wong WM, Chan AO, Yuen MF, Lam SK, Kung HF and Wong BC. (2003). Cancer Res., 63, 7724-7732.
47. Uren AG, Wong L, Pakusch M, Fowler KJ, Burrows FJ, Vaux DL and Choo KH. (2000). Curr. Biol., 10, 1319-1328.
48. Velculescu VE, Madden SL, Zhang L, Lash AE, Yu J, Rago C, Lal A, Wang CJ, Beaudry GA, Ciriello KM, Cook BP, Dufault MR, Ferguson AT, Gao Y, He TC, Hermeking H, Hiraldo SK, Hwang PM, Lopez MA, Luderer HF, Mathews B, Petroziello JM, Polyak K, Zawel L and Kinzler KW. (1999). Nat. Genet., 23, 387-388.
49. Xu ZX, Zhao RX, Ding T, Tran TT, Zhang W, Pandolfi PP and Chang KS. (2004). J. Biol. Chem., 16, 1838-1844.
50. Yamauchi T, Oike Y, Kamon J, Waki H, Komeda K, Tsuchida A, Date Y, Li MX, Miki H, Akanuma Y, Nagai R, Kimura S, Saheki T, Nakazato M, Naitoh T, Yamamura K and Kadowaki T. (2002). Nat. Genet., 30, 221-226.
51. Yao TP, Oh SP, Fuchs M, Zhou ND, Chang LE, Newsome D, Bronson RT, Li E, Livingston DM and Eckner R. (1998). Cell, 93, 361-372.
52. Zhang T, Otevrel T, Gao Z, Gao Z, Ehrlich SM, Fields JZ and Boman BM. (2001). Cancer Res., 61, 8664-8667.